WO2024263803A3 - Nouveaux modulateurs de fshr et leurs utilisations - Google Patents
Nouveaux modulateurs de fshr et leurs utilisations Download PDFInfo
- Publication number
- WO2024263803A3 WO2024263803A3 PCT/US2024/034851 US2024034851W WO2024263803A3 WO 2024263803 A3 WO2024263803 A3 WO 2024263803A3 US 2024034851 W US2024034851 W US 2024034851W WO 2024263803 A3 WO2024263803 A3 WO 2024263803A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fshr
- novel modulators
- modulators
- novel
- fsh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pregnancy & Childbirth (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne des composés modulateurs de FSH de formule (I) et des sels pharmaceutiquement acceptables de ceux-ci.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363522292P | 2023-06-21 | 2023-06-21 | |
| US63/522,292 | 2023-06-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2024263803A2 WO2024263803A2 (fr) | 2024-12-26 |
| WO2024263803A3 true WO2024263803A3 (fr) | 2025-05-01 |
Family
ID=93936387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2024/034851 Pending WO2024263803A2 (fr) | 2023-06-21 | 2024-06-20 | Nouveaux modulateurs de fshr et leurs utilisations |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2024263803A2 (fr) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008035356A2 (fr) * | 2006-09-20 | 2008-03-27 | Glenmark Pharmaceuticals Limited | Nouveaux ligands de récepteur cannabinoïde, compositions pharmaceutiques les contenant, et procédé associé à leur préparation |
| US20100215741A1 (en) * | 2009-02-25 | 2010-08-26 | Neuroscienze Pharmaness S.C. A.R.L. | Pharmaceutical compounds |
| WO2014209980A1 (fr) * | 2013-06-24 | 2014-12-31 | Merck Patent Gmbh | Composés de pyrazole à titre de modulateurs de fshr et leurs utilisations |
| WO2015196759A1 (fr) * | 2014-06-23 | 2015-12-30 | Tocopherx, Inc. | Composés de pyrazole utilisés en tant que modulateurs de fshr et leurs utilisations |
| WO2024044778A2 (fr) * | 2022-08-26 | 2024-02-29 | Celmatix Inc. | Nouveaux modulateurs de fshr et leurs utilisations |
-
2024
- 2024-06-20 WO PCT/US2024/034851 patent/WO2024263803A2/fr active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008035356A2 (fr) * | 2006-09-20 | 2008-03-27 | Glenmark Pharmaceuticals Limited | Nouveaux ligands de récepteur cannabinoïde, compositions pharmaceutiques les contenant, et procédé associé à leur préparation |
| US20100215741A1 (en) * | 2009-02-25 | 2010-08-26 | Neuroscienze Pharmaness S.C. A.R.L. | Pharmaceutical compounds |
| WO2014209980A1 (fr) * | 2013-06-24 | 2014-12-31 | Merck Patent Gmbh | Composés de pyrazole à titre de modulateurs de fshr et leurs utilisations |
| WO2015196759A1 (fr) * | 2014-06-23 | 2015-12-30 | Tocopherx, Inc. | Composés de pyrazole utilisés en tant que modulateurs de fshr et leurs utilisations |
| WO2024044778A2 (fr) * | 2022-08-26 | 2024-02-29 | Celmatix Inc. | Nouveaux modulateurs de fshr et leurs utilisations |
Non-Patent Citations (2)
| Title |
|---|
| DATABASE Pubmed U.S. National Library of Medicine; 17 August 2024 (2024-08-17), ANONYMOUS: "Ethyl 3-(2,4-dichlorophenyl)-12-(3-fluoropropyl)-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaene-5-carboxylate", XP009563379, Database accession no. 134840788 * |
| PLESSIS ET AL.: "Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility", JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, vol. 32, 16 August 2015 (2015-08-16), pages 1575 - 1588, XP035912802, DOI: 10.1007/s10815-015-0553-8 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024263803A2 (fr) | 2024-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4438122A3 (fr) | Composé peptidique court à base de proline à cycle modifié et son utilisation | |
| WO2021079196A3 (fr) | Modulateurs de mettl3 | |
| ZA202410007B (en) | Pyrimidine based modulators and uses thereof | |
| MX2023014620A (es) | Nuevos profarmacos y conjugados de dimetiltriptamina. | |
| WO2002071827A3 (fr) | Modulateurs des recepteurs x de retinoides | |
| NO20051328L (no) | Kalsiumreseptormodulerende forbindelse og anvendelse derav | |
| WO2005103003A3 (fr) | Inhibiteurs de l'enzyme integrase du vih | |
| ATE184281T1 (de) | 9-hydroxy-pyrido (1,2-a> pyrimidin-4-on-ether- derivate | |
| MX2023010125A (es) | Inhibidores del sarcomero cardiaco. | |
| CA3248327A1 (fr) | Composés pyrrolidine | |
| MX2025002166A (es) | Compuestos y metodos para modular her2 | |
| WO2024123815A8 (fr) | Procédé de synthèse de modulateurs de tétrahydrofurane substitués de canaux sodiques | |
| MX2021011374A (es) | Compuestos de heteroaril(heterocyclil)metanol útiles en el tratamiento de la hiperglucemia. | |
| WO2024263803A3 (fr) | Nouveaux modulateurs de fshr et leurs utilisations | |
| WO2024254511A3 (fr) | Inhibiteurs de wrn | |
| MX2025000059A (es) | Compuesto de sulfoximina con efecto inhibidor de fgfr, composicion farmaceutica que lo comprende y su uso | |
| WO2022031862A3 (fr) | Composés hétéroaryle et hétérocyclyle | |
| WO2021226276A3 (fr) | Modulateurs de nampt | |
| WO2023147063A3 (fr) | Composés et procédés de modulation de yap/tead et indications associées | |
| WO2024044778A3 (fr) | Nouveaux modulateurs de fshr et leurs utilisations | |
| EP4545078A3 (fr) | Composé benzo 2-azaspiro[4.4nonane et son utilisation | |
| WO2022272036A9 (fr) | Inhibiteurs de tead et leurs utilisations | |
| WO2022234337A3 (fr) | Dérivé de carbazole cristallin | |
| MX2023006176A (es) | Nuevos derivados de indazol acetileno. | |
| WO2024036288A3 (fr) | Agonistes inverses de gpr6 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 24826664 Country of ref document: EP Kind code of ref document: A2 |